5HT2c receptor agonists for the treatment of diabetes and obesity

Details for Australian Patent Application No. 2004251847 (hide)

Owner F. Hoffmann-La Roche AG Vernalis Research Limited

Inventors Blench, Toby Jonathan; Roever, Stephan; Hebeisen, Paul; Richter, Hans

Agent Spruson & Ferguson

Pub. Number AU-B-2004251847

PCT Pub. Number WO2005/000849

Priority 0314967.1 26.06.03 GB

Filing date 18 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 23 August 2007

International Classifications

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/000849 Priority application(s): WO2005/000849

23 August 2007 Application Accepted

  Published as AU-B-2004251847

24 January 2008 Standard Patent Sealed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251849-Unidirectional lighting device for illuminating objects and/or for marking lanes, preferably in the airport area

2004251846-Biaryloxymethylarene-carboxylic acids